Fanconi syndrome differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 16: Line 16:
** Distal [[RTA]]
** Distal [[RTA]]


===Preferred Table<ref name="pmid22990302">{{cite journal| author=Viganò C, Amoruso C, Barretta F, Minnici G, Albisetti W, Syrèn ML et al.| title=Renal phosphate handling in Gitelman syndrome--the results of a case-control study. | journal=Pediatr Nephrol | year= 2013 | volume= 28 | issue= 1 | pages= 65-70 | pmid=22990302 | doi=10.1007/s00467-012-2297-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22990302  }}</ref>===
===Preferred Table<ref name="pmid22990302">{{cite journal| author=Viganò C, Amoruso C, Barretta F, Minnici G, Albisetti W, Syrèn ML et al.| title=Renal phosphate handling in Gitelman syndrome--the results of a case-control study. | journal=Pediatr Nephrol | year= 2013 | volume= 28 | issue= 1 | pages= 65-70 | pmid=22990302 | doi=10.1007/s00467-012-2297-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22990302 }}</ref><ref name="pmid24902942">{{cite journal| author=Bettinelli A, Viganò C, Provero MC, Barretta F, Albisetti A, Tedeschi S et al.| title=Phosphate homeostasis in Bartter syndrome: a case-control study. | journal=Pediatr Nephrol | year= 2014 | volume= 29 | issue= 11 | pages= 2133-8 | pmid=24902942 | doi=10.1007/s00467-014-2846-z | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24902942 }}</ref>===
{|
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
Line 67: Line 67:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #F5F5F5; padding: 5px;" |N
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |'''<big>↓/</big>N'''
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
|'''<big>-</big>'''
|'''<big>-</big>'''
Line 85: Line 85:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #F5F5F5; padding: 5px;" |N
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |'''<big>↓/</big>N'''
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
|'''<big>-</big>'''
|'''<big>-</big>'''
Line 100: Line 100:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |RTA Type IV
| style="background: #DCDCDC; padding: 5px; text-align: center;" |RTA Type IV
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |'''<big>-/+</big>'''
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #F5F5F5; padding: 5px;" |N
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px;" |
! style="background: #F5F5F5; padding: 5px;" |N
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
|'''<big>-</big>'''
|'''<big>-</big>'''
Line 141: Line 141:
| style="background: #F5F5F5; padding: 5px;" |      '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px;" |      '''<big>↓</big>'''
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
! style="background: #F5F5F5; padding: 5px;" |N
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
| style="background: #F5F5F5; padding: 5px;" |'''<big>-</big>'''
|'''<big>-</big>'''
|'''<big>-</big>'''
Line 159: Line 159:
|      '''<big>↓</big>'''
|      '''<big>↓</big>'''
|'''<big>-</big>'''
|'''<big>-</big>'''
|   '''<big>-/+</big>'''
|'''<big>/</big>N'''
|'''<big>-</big>'''
|'''<big>-</big>'''
|'''<big>-</big>'''
|'''<big>-</big>'''
|
|'''<big>↓</big>'''
|  '''<big>↓/</big>N'''
|  '''<big>↓/</big>N'''
|  '''<big>↓/</big>N'''
|  '''<big>↓/</big>N'''

Revision as of 16:15, 18 June 2018

Fanconi syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fanconi syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study Of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fanconi syndrome differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fanconi syndrome differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fanconi syndrome differential diagnosis

CDC on Fanconi syndrome differential diagnosis

Fanconi syndrome differential diagnosis in the news

Blogs on Fanconi syndrome differential diagnosis

Directions to Hospitals Treating Fanconi syndrome

Risk calculators and risk factors for Fanconi syndrome differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Fnaconi syndrome is characterized by freely losses of water, HCO3-, Na+ and K+, all classes of aminoacids, uric acid, LMW nutrients, and glucose in line with evidence of proximal renal tubular acidosis(P-RTA). It has been mentioned that one or two of the above substances can have normal renal excertion and the disease still be called (however incomplete) Fanconi syndrome.

Differentiating "Fanconi syndrome" from other Diseases

  • The differential diagnosis(DDx) of the syndrome is mainly done on the basis of clinical and laboratory findings. Hence the disease must be differentiated with all of the other conditions which partly present its characteristics and clinical findings (and so cannot be called Fanconi syndrome yet) or just have some limited features in common. The most important DDxs are:

Preferred Table[1][2]

Diseases Clinical manifestations Para-clinical findings Additional findings
Symptoms Physical examination
Lab Findings
Dehydration Lethargy Musculoskeletal pain Blood Pressure Edema Growth Proteinuria Aminoaciduria Serum Phosphate Serum [Na+] Serum [K+] Anion Gap Serum PH Urine PH Urine [Ca2+]
Fanconi Syndrome + + + -/+ + + ↓/N ↓/N N 5.5 ↓/N
Proximal RTA - N - ↓/N - - N N ↓/N N 5.5 N
Distal RTA N - ↓/N - - N N ↓/N N 5.5
RTA Type IV - -/+ -/+ N - N - - N ↓ ↓ ↑ ↑ N 5.5 ↓/N
Nephrotic Syndrome + + + - N ↓/N N ↓/N N N N
Gitelman syndrome + - N - - ↓/N ↓/N ↑/N 5.5
Bartter's syndrome + - ↓/N - - ↓/N ↓/N ↑/N 5.5

References

  1. Viganò C, Amoruso C, Barretta F, Minnici G, Albisetti W, Syrèn ML; et al. (2013). "Renal phosphate handling in Gitelman syndrome--the results of a case-control study". Pediatr Nephrol. 28 (1): 65–70. doi:10.1007/s00467-012-2297-3. PMID 22990302.
  2. Bettinelli A, Viganò C, Provero MC, Barretta F, Albisetti A, Tedeschi S; et al. (2014). "Phosphate homeostasis in Bartter syndrome: a case-control study". Pediatr Nephrol. 29 (11): 2133–8. doi:10.1007/s00467-014-2846-z. PMID 24902942.

Template:WH Template:WS